Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Analyst Forecast

$36.68

north_east $0.26 (0.71%)
Day's range
$36.03
Day's range
$37.27

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
12/04/2024 RBC Capital Leonid Timashev $61.00 $46.58   30.97%
10/15/2024 Bank of America Securities Jason Gerberry $65.00 $52.77   23.18%
09/24/2024 Leerink Partners Marc Goodman $60.00 $44.22   35.69%
09/24/2024 H.C. Wainwright Douglas Tsao $59.00 $45.94   28.43%
09/24/2024 Bank of America Securities Jason Gerberry $62.00 $45.94   34.96%
09/24/2024 RBC Capital Leonid Timashev $68.00 $45.94   48.02%
09/23/2024 BTIG Thomas Shrader $59.00 $46.56   26.72%
09/23/2024 Robert W. Baird Brian Skorney $60.00 $46.56   28.87%
09/16/2024 Jefferies Amy Li $57.00 $38.08   49.68%
09/04/2024 Tudor Pickering William Pickering $55.00 $38.17   44.09%
07/24/2024 Morgan Stanley Terence Flynn $58.00 $37.81   53.4%
05/29/2024 Robert W. Baird Brian Skorney $58.00 $30.31   91.36%
05/29/2024 RBC Capital Leonid Timashev $59.00 $28.69   105.65%

Biohaven Pharmaceutical Holding Company Ltd. FAQ's

What analysts cover Biohaven Pharmaceutical Holding Company Ltd.?

Biohaven Pharmaceutical Holding Company Ltd. has been rated by research analysts at RBC Capital, Bank of America Securities, Leerink Partners, H.C. Wainwright, BTIG, Robert W. Baird in the past 90 days.